Movie Reviewing - A Prospective Incidental Learning Approach in English Language Acquisition

In applied linguistics, the practice of incidental learning i.e., learning without conscious purpose of committing the learning instructions to memory, is broadly recommended for effective Second Language Acquisition (SLA). Besides, the advent and applications of new technologies provide immense opportunities to promote and endorse incidental learning in L2 classrooms. In recent interdisciplinary respects, the integration of media studies in tertiary level English language learning curricula is reckoned to be a sensible interdisciplinary approach with potential outcomes. And, observing the long-term consumption of media, it is also quite perceptible that Indian consumerism to cinema and its offshoots is naturally on the rise. With this understanding, this research article explores the areas for English language skills development taking into account of the perks of incidental learning particularly through learners’ regular experience with movie reviews

Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study

18% of the world's population lives in India, and many states of India have populations similar to those of large countries. Action to effectively improve population health in India requires availability of reliable and comprehensive state-level estimates of disease burden and risk factors over time. Such comprehensive estimates have not been available so far for all major diseases and risk factors. Thus, we aimed to estimate the disease burden and risk factors in every state of India as part of the Global Burden of Disease (GBD) Study 2016

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Is cashew nut shell liquid a causative factor for oral submucous fibrosis?. A study among cashew nut industrial workers

Background: Cashew nut shell liquid contains 90% anacardic acid and 10% cardol. This liquid when comes in contact topically is said to have deleterious effects both orally and systemically. Aim: The present cross-sectional study was conducted to assess the prevalence of oral submucous fibrosis (OSMF) among 600 cashew nut industrial workers in Kanyakumari district. Materials and Methods: Demographic data and tobacco habits were assessed using pretested questionnaire. Ranganathan K clinical grading system was used to examine OSMF. The data were assessed using SPSS version 11.5. Results: The overall prevalence of OSMF among the study population was 0.002%. Conclusion: The observation from this study clearly indicates that safe working environment prevents occupational hazards

Gender difference in blood pressure, blood sugar, and cholesterol in young adults with comparable routine physical exertion

Context: Gender differences in the risk of developing non-communicable diseases (NCD) are a matter of debate. The susceptibility of a woman to NCD should be evaluated taking into consideration the social factors that limit the physical activity among women. It will be interesting to note what will happen if women are allowed to take part in physical exercise to the extent of men. Aims: To find out the gender difference in the pattern of the clinical and biochemical indices related to NCD in young adults with comparable daily physical activity. Settings and Design: This is an institution-based cross-sectional study and the setting was Lekshmibhai National College for Physical Education (LNCPE), Thiruvananthapuram, Kerala, India. Materials and Methods: The study participants were students who were regularly involved in more than three hours of physical exercise daily at least for the previous one year. The information on socio-demography, anthropometry, and blood pressure was recorded. Blood samples were taken for laboratory examination. Results: Out of 150 students registered, 126 (84%) in the age group of 17 to 25 years who fulfilled the eligibility criteria were studied. Fifty-five (43.7%) of them were women. Systolic blood pressure, fasting blood sugar, and low-density lipoprotein were found significantly lower in women. No significant difference was noted in the case of diastolic blood pressure and total cholesterol. Conclusion: Gender differences exist for NCD risk factors among young adults with comparable physical activity and physical exertion seems to be more protective for females

First Person View Camera Based Quadcopter with Raspberry Pi

This paper studies in details about the need of quadcopter in various fields especially in the place of remote area where the road transportation facility is very less. It is used to monitor and collect data in a specific region. The movement of this quadcopter is controlled by the Raspberry Pi. FPV camera is used for capturing the image and will transmit the image to the receiver which can be monitored using an android smart phone. This is mainly used for surveillance purpose and hidden activities can be captured

Taking Well-Being Seriously – Our Clinical Learning Environment (CLE) Partnership Strategy

Introduction/Background Physician well-being has become a national issue as it impacts patient safety and quality of care, workforce and culture. Nationally and within our health care system there are multiplying discussions and emerging initiatives around well-being from the ACGME’s Symposium of Physician Well-Being and AHME’s webinars and academy conference to the AAMC’s and AIAMC’s annual meeting and workshops. The number of options and evidence-based strategies are bewildering. How much do you focus on the individual? What role does the environment redesign play? How can we turn these evolving discussions into an opportunity for GME? At Aurora Health Care, we have utilized our CLER-established partnerships - composed of system, hospital, physician education and GME leaders - to identity “shared pain points” and implement a consistent strategy across our hospitals/programs. Hypothesis/Aim Statement To utilize our CLER Synergy Group to coalesce and leverage the system/hospital well-being across the continuum of medical education. Methods Working with CLER synergy partners, resident council and physician education leaders we sought to identify current/pending initiatives around physician well-being. The synergy group reviewed the initiatives to determine initiatives that would cut across all levels of physician training. Results Through our CLER Synergy group, chaired by our DIO, we are partnering with CMO’s, Medical Education Continuum Leaders, Resident Council & GME Leaders, and experts in well-being and medical education. Our multi-pronged strategy includes: Well-being is included as one of four options for GME Shared Noon Conference resident/faculty program teams to meet quality improvement project options during 2016-2017 Assessment of Physicians and Residents/Fellows use of nationally available/established burnout inventory Make clinician satisfaction and well-being GME quality indicators Design and implement a CME – Performance Improvement Clinical Quality Improvement (CQI) activity (Part IV MOC Points) well-being initiative requiring both individual and environment change metrics available to all physicians and medical students Leverage well-being programs under development within the system (e.g., Employee Health) Utilizing data from burnout inventory to Identify and implement well-being initiatives using a train-the-trainer model for GME program leaders through a GME retreat Conclusions Utilizing our CLER Synergy Group to address physician well-being allows GME to be placed in a key leadership role within the organization as we align our initiatives with hospital/system priorities

Recommendations for developing effective and safe paediatric and congenital heart disease services in low-income and middle-income countries: a public health framework

The global burden of paediatric and congenital heart disease (PCHD) is substantial. We propose a novel public health framework with recommendations for developing effective and safe PCHD services in low-income and middle-income countries (LMICs). This framework was created by the Global Initiative for Children’s Surgery Cardiac Surgery working group in collaboration with a group of international rexperts in providing paediatric and congenital cardiac care to patients with CHD and rheumatic heart disease (RHD) in LMICs. Effective and safe PCHD care is inaccessible to many, and there is no consensus on the best approaches to provide meaningful access in resource-limited settings, where it is often needed the most. Considering the high inequity in access to care for CHD and RHD, we aimed to create an actionable framework for health practitioners, policy makers and patients that supports treatment and prevention. It was formulated based on rigorous evaluation of available guidelines and standards of care and builds on a consensus process about the competencies needed at each step of the care continuum. We recommend a tier-based framework for PCHD care integrated within existing health systems. Each level of care is expected to meet minimum benchmarks and ensure high-quality and family centred care. We propose that cardiac surgery capabilities should only be developed at the more advanced levels on hospitals that have an established foundation of cardiology and cardiac surgery services, including screening, diagnostics, inpatient and outpatient care, postoperative care and cardiac catheterisation. This approach requires a quality control system and close collaboration between the different levels of care to facilitate the journey and care of every child with heart disease. This effort was designed to guide readers and leaders in taking action, strengthening capacity, evaluating impact, advancing policy and engaging in partnerships to guide facilities providing PCHD care in LMICs